Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells
In colorectal cancer (CRC), a subpopulation of tumor cells, called cancer stem cell (CSC) fraction, is suggested to be responsible for tumor initiation, growth, and metastasis. The search for a reliable marker to identify these CSCs is ongoing as current markers, like CD44 and CD133, are more broadl...
Saved in:
Published in: | Stem cells (Dayton, Ohio) Vol. 30; no. 11; pp. 2378 - 2386 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-11-2012
Oxford University Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In colorectal cancer (CRC), a subpopulation of tumor cells, called cancer stem cell (CSC) fraction, is suggested to be responsible for tumor initiation, growth, and metastasis. The search for a reliable marker to identify these CSCs is ongoing as current markers, like CD44 and CD133, are more broadly expressed and therefore are not highly selective and currently also lack function in CSC biology. Here, we analyzed whether the Wnt target Lgr5, which has earlier been identified as a marker for murine intestinal stem cells, could potentially serve as a functional marker for CSCs. Fluorescence‐activated cell sorting‐based detection of Lgr5, using three newly developed antibodies, on primary colorectal tumor cells revealed a clear subpopulation of Epcam+Lgr5+ cells. Similarly, primary CRC‐derived spheroid cultures, known to be enriched for CSCs, contain high levels of Lgr5+ cells, which decrease upon in vitro differentiation of these CSCs. Selection of the Lgr5high CRC cells identified the clonogenic fraction in vitro as well as the tumorigenic population in vivo. Finally, we confirm that Lgr5 expression is dependent on the Wnt pathway and show that Lgr5 overexpression induces clonogenic growth. We thus provide evidence that Lgr5 is, next to a functional intestinal stem cell marker, a selective marker for human colorectal CSCs. STEM CELLS2012;30:2378–2386 |
---|---|
Bibliography: | VICI grant of NWO istex:7FA82B1CF2C2D2FA302A0D3CDAB2E2791523AF2C ArticleID:STEM1233 Author contributions: K.K.: conception and design, collection and/or assembly of data, data analysis and interpretation, and manuscript writing; W.D.L.: conception and design and provision of study material; P.R.P.: provision of study material, collection and/or assembly of data, and data analysis and interpretation.; H.R.: collection and/or assembly of data; H.C.: conception and design and final approval of manuscript; J.P.M.: conception and design, data analysis and interpretation, and final approval of manuscript. Disclosure of potential conflicts of interest is found at the end of this article. First published online in STEM CELLSEXPRESS August 7, 2012. Dutch Cancer Society - No. UvA 2009-4416 AMC graduate school scholarship ark:/67375/WNG-G73ZHLVF-L August 7, 2012. First published online in S Telephone: +31‐20‐5667777; Fax: +31‐20‐6977192 C XPRESS E TEM ELLS ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1066-5099 1549-4918 |
DOI: | 10.1002/stem.1233 |